• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number MA60MA
Medical Device Problem Code Defective Component (2292)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 03/03/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lens was returned for evaluation.Solution and blood are dried on the lens.One haptic is bent in the gusset area and folded over and adhered to the optic by solution and blood.The opposite haptic is bent in several areas and broken in the distal area.The optic is cut in half, typical of insertion and removal from the eye.The optic is broken and crushed over a post in the lens case.All product and batch history records are quality reviewed prior to product release.The file indicates the use of a non-qualified cartridge, handpiece and viscoelastic.Broken haptic damage was observed.The root cause is most likely related a failure to follow the ifu (instructions for use).The account used an unqualified lens/company delivery system combination.The ifu instructs that an company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.There are no other complaints in this lot.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A facility representative reported that during implantation of intraocular lens (iol) procedure, it was found that haptic would not unfold in the patients eye.The surgeon had removed the iol during initial procedure.Additional information received and stated that, the incision was enlarged and suture was used during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF MULTIPIECE IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key14039743
Report Number1119421-2022-00692
Device Sequence Number6301276
Product Code HQL
UDI-Device Identifier00380650699312
UDI-Public00380650699312
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 04/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/17/2026
Device Model NumberMA60MA
Device Catalogue NumberMA60MAN030
Device Lot Number15200180
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/15/2022
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/15/2022
Initial Report FDA Received Date04/07/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/19/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMIVISIC; MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; MONARCH III IOL DELIVERY SYSTEM, INJECTOR
Outcome Attributed to Adverse Event Required Intervention;
Patient Age73 YR
Patient SexMale
-
-